Mark Knautz
Dermatology · Powder Springs, GANPI 1790743300
Payments from drug & device makers
Across 939 payments — averaging $1821.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$470K
- Takeda Pharmaceuticals U.S.A., Inc.$305K
- Eli Lilly$300K
- E.r. Squibb & Sons, L.L.C.$244K
- Incyte Corporation$233K
- Novartis$64K
- plus $95K from 26 others
Across 4 payments — averaging $4286.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$17K
- Eli Lilly$295
What the payments were for
- Food & beverage$8,48497%
- Education$2923%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 199 | $469,576 |
| Takeda Pharmaceuticals U.S.A., Inc. | 33 | $304,912 |
| Eli Lilly | 22 | $299,552 |
| E.r. Squibb & Sons, L.L.C. | 22 | $244,324 |
| Incyte Corporation | 318 | $232,728 |
| Novartis | 21 | $64,480 |
| Amgen | 3 | $43,632 |
| Dermira, Inc. | 7 | $21,817 |
| Pfizer | 11 | $10,730 |
| Regeneron | 18 | $8,581 |
| Dr.reddy's Laboratories,inc. | 2 | $4,229 |
| Sanofi | 59 | $1,991 |
| Johnson & Johnson | 75 | $1,258 |
| Regeneron Healthcare Solutions, Inc. | 53 | $1,230 |
| Dermavant Sciences, Inc. | 26 | $325 |
| Galderma Laboratories, L.p. | 16 | $205 |
| LEO Pharma Inc. | 10 | $191 |
| UCB, Inc. | 7 | $146 |
| Botanix SB Inc | 7 | $140 |
| Arcutis Biotherapeutics, Inc. | 4 | $77 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $74 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Boehringer Ingelheim | 3 | $61 |
| Almirall LLC | 2 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Sun Pharmaceutical Industries Inc. | 2 | $42 |
| Organon | 2 | $35 |
| Mayne Pharma Commercial LLC | 3 | $33 |
| Kerecis Limited | 1 | $28 |
| Paratek Pharmaceuticals, Inc. | 1 | $27 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Prugen, Inc. Pharmaceuticals | 1 | $11 |
How this compares
$1,710,619 in reported general payments places this provider in the 95th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 17 | $342,460 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 17 | $188,997 |
| Dupixent SyringeDupilumab | 34 | $128,673 |
| Dupixent PenDupilumab | 11 | $40,786 |
| Ketoconazole | 298 | $3,481 |
| Metronidazole | 60 | $2,952 |
| Clindamycin Phosphate | 29 | $2,184 |
| Clobetasol Propionate | 68 | $1,757 |
| Doxycycline Hyclate | 77 | $1,643 |
| ValacyclovirValacyclovir Hcl | 53 | $1,597 |
| Triamcinolone Acetonide | 134 | $1,554 |
| Ciclopirox | 50 | $1,520 |
| Dapsone | 21 | $1,195 |
| Fluocinolone Acetonide | 28 | $1,098 |
| Desonide | 24 | $1,074 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Powder Springs
- David CohenMacon$5.5M
- Jamie WeismanAtlanta$4.9M
- Tiffani HamiltonAlpharetta$3.3M
- Firas HougeirDouglasville$3.3M
- Jonathan WeissSnellville$2.4M
- Gerald SlagelFayetteville$1.2M
- Zakiya RiceAtlanta$1.1M
- Corinne HowingtonSavannah$874K
- Alia BrownSnellville$838K
- Joseph PayneAtlanta$722K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.